Muheng Capital Partners (Hong Kong) Limited - Net Worth and Insider Trading
Muheng Capital Partners (Hong Kong) Limited Net Worth
The estimated net worth of Muheng Capital Partners (Hong Kong) Limited is at least $139 Million dollars as of 2024-06-23. Muheng Capital Partners (Hong Kong) Limited is the 2101 Beneficial owner of Venus Medtech (Hangzhou) Inc and owns about 24,713,752 shares of Venus Medtech (Hangzhou) Inc (HKSE:02500) stock worth over $139 Million. Details can be seen in Muheng Capital Partners (Hong Kong) Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Muheng Capital Partners (Hong Kong) Limited has not made any transactions after 2022-11-22 and currently still holds the listed stock(s).
Transaction Summary of Muheng Capital Partners (Hong Kong) Limited
Muheng Capital Partners (Hong Kong) Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Muheng Capital Partners (Hong Kong) Limited owns 1 companies in total, including Venus Medtech (Hangzhou) Inc (HKSE:02500) .
Insider Ownership Summary of Muheng Capital Partners (Hong Kong) Limited
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02500 | Venus Medtech (Hangzhou) Inc | 2022-11-22 | 2101 Beneficial owner |
Muheng Capital Partners (Hong Kong) Limited Latest Holdings Summary
Muheng Capital Partners (Hong Kong) Limited currently owns a total of 1 stock. Muheng Capital Partners (Hong Kong) Limited owns 24,713,752 shares of Venus Medtech (Hangzhou) Inc (HKSE:02500) as of November 22, 2022, with a value of $139 Million.
Latest Holdings of Muheng Capital Partners (Hong Kong) Limited
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02500 | Venus Medtech (Hangzhou) Inc | 2022-11-22 | 24,713,752 | 5.62 | 138,891,286 |
Holding Weightings of Muheng Capital Partners (Hong Kong) Limited
Muheng Capital Partners (Hong Kong) Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, Muheng Capital Partners (Hong Kong) Limited has made a total of 2 transactions in Venus Medtech (Hangzhou) Inc (HKSE:02500) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Venus Medtech (Hangzhou) Inc is the acquisition of 219,500 shares on November 22, 2022, which cost Muheng Capital Partners (Hong Kong) Limited around $3 Million.
Insider Trading History of Muheng Capital Partners (Hong Kong) Limited
- 1
Muheng Capital Partners (Hong Kong) Limited Trading Performance
GuruFocus tracks the stock performance after each of Muheng Capital Partners (Hong Kong) Limited's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Muheng Capital Partners (Hong Kong) Limited is 47.89%. GuruFocus also compares Muheng Capital Partners (Hong Kong) Limited's trading performance to market benchmark return within the same time period. The performance of stocks bought by Muheng Capital Partners (Hong Kong) Limited within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Muheng Capital Partners (Hong Kong) Limited's insider trading performs compared to the benchmark.
Performance of Muheng Capital Partners (Hong Kong) Limited
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.24 | | | | | |
| Relative Return to S&P 500(%) | 19.69 | | | | | |
Muheng Capital Partners (Hong Kong) Limited Ownership Network
Muheng Capital Partners (Hong Kong) Limited Owned Company Details
What does Venus Medtech (Hangzhou) Inc do?
Who are the key executives at Venus Medtech (Hangzhou) Inc?
Muheng Capital Partners (Hong Kong) Limited is the 2101 Beneficial owner of Venus Medtech (Hangzhou) Inc. Other key executives at Venus Medtech (Hangzhou) Inc include 2201 Interest of corporation controlled by you Zeng Min Frank , 2201 Interest of corporation controlled by you Zi Zhenjun , and 2101 Beneficial owner Ming Zhi Investments (bvi) Limited .
Venus Medtech (Hangzhou) Inc (HKSE:02500) Insider Trades Summary
Over the past 18 months, Muheng Capital Partners (Hong Kong) Limited made no insider transaction in Venus Medtech (Hangzhou) Inc (HKSE:02500). Other recent insider transactions involving Venus Medtech (Hangzhou) Inc (HKSE:02500) include a net purchase of 446,500 shares made by Zi Zhenjun , a net sale of 327,000 shares made by Qiming Corporate GP III, Ltd. , and a net sale of 327,000 shares made by Qiming GP III, L.P. .
In summary, during the past 3 months, insiders sold 0 shares of Venus Medtech (Hangzhou) Inc (HKSE:02500) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,130,637 shares of Venus Medtech (Hangzhou) Inc (HKSE:02500) were sold and 446,500 shares were bought by its insiders, resulting in a net sale of 684,137 shares.
Venus Medtech (Hangzhou) Inc (HKSE:02500)'s detailed insider trading history can be found in Insider Trading Tracker table.
Venus Medtech (Hangzhou) Inc Insider Transactions
Muheng Capital Partners (Hong Kong) Limited Mailing Address
Above is the net worth, insider trading, and ownership report for Muheng Capital Partners (Hong Kong) Limited. Currently GuruFocus does not have mailing address information for Muheng Capital Partners (Hong Kong) Limited.
Discussions on Muheng Capital Partners (Hong Kong) Limited
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
